A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure
… This could also explain why trimetazidine seems particularly effective in diabetic patients (18,31). However, in the present study we could not confirm this issue because the diabetic …..... Read More